Category: Case Studies

We conducted a pricing strategy assessment for a mid-sized international pharmaceutical company in the process of developing a new product in a specialty therapeutic area. The project included interviews with 25 pharmacy directors and 25 physicians, covering 209 million lives in the United States and ten payers in the EU5.

We worked with a US-based biopharmaceutical company with a solid oral product in an established, competitive disease state to gain payer insights into drug pricing and optimize PRMA in multiple countries.

A small to mid-sized US pharmaceutical manufacturer preparing to launch a new product hired us to maximize their positioning within a competitive market landscape. The project objectives were wide-ranging, consisting of segmenting payers to understand volume and access contribution, prioritizing MCO accounts, and selectively contracting to improve access and utilization management (UM).

We worked with a mid-sized pharmaceutical manufacturer based in the US preparing to launch a product in a competitive market. The client hired us to evaluate four to six possible marketplace scenarios to determine possible appropriate actions under certain marketplace conditions.